ALGS vs TFC · rev $3.6M vs rev $24.54B
Aligos Therapeutics Inc (ALGS) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
TFC (TFC) common stock.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
ALGS currently screens at market cap $44.1M. TFC currently screens at market cap $0.
Not investment advice. Open the ALGS and TFC stock pages for the full models.
Not investment advice.